Back to News
Market Impact: 0.3

NuScale Power vs. Nano Nuclear: Which Nuclear Stock Has an Edge Now?

SMRNNE
Technology & InnovationRenewable Energy TransitionCompany FundamentalsCorporate EarningsAnalyst EstimatesAnalyst InsightsRegulation & Legislation
NuScale Power vs. Nano Nuclear: Which Nuclear Stock Has an Edge Now?

NuScale Power (SMR) and Nano Nuclear Energy (NNE) are key players in the expanding small modular reactor (SMR) and microreactor markets, projected to reach $8.37 billion by 2032. NuScale, focusing on large-scale SMRs, has secured a landmark 6 GW agreement with the Tennessee Valley Authority and seen 91.4% YTD stock appreciation, yet faces an 'overvalued' assessment and a Zacks 'Sell' rating. Conversely, pre-revenue Nano Nuclear, specializing in microreactors, is positioned for long-term upside via a 10-year R&D partnership with Idaho National Lab, despite a more modest 26.3% YTD gain and a Zacks 'Hold' rating, highlighting a strategic divergence between current commercialization and future growth potential in the advanced nuclear sector.

Analysis

The small modular reactor (SMR) market, projected to grow at a 4.98% CAGR to $8.37 billion by 2032, is a key battleground for NuScale Power (SMR) and Nano Nuclear Energy (NNE), which exhibit a clear strategic divergence. NuScale, focused on large-scale SMRs, has achieved significant commercial traction with a landmark agreement to deploy up to 6 gigawatts for the Tennessee Valley Authority, fueling a 91.4% year-to-date share price increase. However, this progress is countered by significant headwinds, including a Zacks Rank #4 (Sell) rating, a high Price/Book valuation of 19.58X, and a deteriorating earnings forecast with a projected loss of 46 cents per share for 2025, compared to earnings of 42 cents in the prior-year quarter. Conversely, Nano Nuclear, a pre-revenue company focused on microreactors, has seen a more modest 26.3% YTD gain. Its investment case is built on long-term potential, anchored by a 10-year R&D agreement with Idaho National Laboratory and a more favorable Zacks Rank #3 (Hold). While it faces significant development and regulatory hurdles, its Price/Book ratio of 5.77X is substantially lower than NuScale's, suggesting a trade-off between NuScale's current commercialization and Nano Nuclear's speculative, partnership-driven growth trajectory.

AllMind AI Terminal